IPO Timeline
Broker Results (T-2)
2021-10-29
Some brokers release in afternoon
Grey Market (T-1)
2021-11-01
Afternoon
HKEX Allotment (T-1)
2021-11-01
Evening
Registrar Allotment (T-1)
2021-11-01
Evening
Listing Day (T)
2021-11-02
First day of trading
Company Overview
| Stock Name | 上海微創醫療機器人(集團)股份有限公司 - B - H股 |
|---|---|
| Stock Code | 02252 |
| Company Full Name | 上海微創醫療機器人(集團)股份有限公司 - B - H股 |
| Industry | 醫療保健 |
| Principal Activities | 主要從事開發、制造及商業化手術機器人。 |
| Listing Date | 2021-11-02 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國上海市自由貿易試驗區張東路1601號1幢B區101室 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | https://www.medbotsurgical.com |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 43.20 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 45.0% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 781,920,000 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 45.8 |
|---|---|
| First Day Open | HK$ 39.8 |
| First Day Change | 6.02% |
| First Day Volume | 21828600.0 |
| First Day Turnover | 960977000.0 |
Use of Proceeds
| Use of Proceeds | 1、約510.1百萬港元（占35.0%）將用于我們的核心產品圖邁； 2、約306.1百萬港元（占21.0%）將用于我們的骨科手術機器人； 3、約276.9百萬港元（占19.0%）將用于我們其他候選產品； 4、約72.9百萬港元（占5.0%）將用于提高制造與供應鏈管理能力； 5、約145.7百萬港元（占10.0%）將用于擴大我們的產品組合； 6、約145.7百萬港元（占10.0%）將用作營運資金及一般公司用途。 |
|---|
Underwriting Syndicate
Joint Sponsors (2)
J.P. Morgan Securities (Far East) Limited CE AAB026
中国国际金融香港证券有限公司 CE AEN894
Overall Coordinators (2)
J.P. Morgan Securities (Asia Pacific) Limited CE AAJ321
中国国际金融香港证券有限公司 CE AEN894
Joint Bookrunners (2)
J.P. Morgan Securities (Asia Pacific) Limited CE AAJ321
中国国际金融香港证券有限公司 CE AEN894
Joint Lead Managers (4)
J.P. Morgan Securities (Asia Pacific) Limited CE AAJ321
中国国际金融香港证券有限公司 CE AEN894
富途证券国际（香港）有限公司 CE AZT137
利弗莫尔证券有限公司 CE BJN764
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Artisan China Post-Venture Master Fund LP | 37,065,600 HKD | — | 2.40% | — | 6 months | 2022-05-02 |
| 2 | Aspex Master Fund | 148,154,400 HKD | — | 9.50% | — | 6 months | 2022-05-02 |
| 3 | CloudAlpha Master Fund | 74,066,400 HKD | — | 4.70% | — | 6 months | 2022-05-02 |
| 4 | Hillhouse Funds | 111,110,400 HKD | — | 7.10% | — | 6 months | 2022-05-02 |
| 5 | LAV Star Limited | 111,110,400 HKD | — | 7.10% | — | 6 months | 2022-05-02 |
| 6 | Snow Lake China Master Fund, Ltd. | 111,110,400 HKD | — | 7.10% | — | 6 months | 2022-05-02 |
| 7 | Yorkool International Limited | 111,110,400 HKD | — | 7.10% | — | 6 months | 2022-05-02 |
Directors & Management
| Chairman | 常兆華 |
|---|---|
| Company Secretary | 楊兆琳 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 微創醫療科學有限公司(52.24%);上海擎赫企業管理咨詢中心(有限合伙)(10.02%);深圳高瓴天成三期投資有限公司(7.7%) |
|---|
IPO Timeline
